#United States #Washington, D.C. #ACON Investments #Vitalis #Sanfan

ACON Investments Concludes Sale of Vitalis

ACON Investments, a middle-market private equity firm headquartered in Washington, D.C., has officially completed the sale of its stake in Vitalis S.A.C.I. to Laboratorios Sanfer, a leading pharmaceutical company based in Mexico. This move not only underscores ACON's long-standing strategy of enhancing its portfolio in Latin America but also illustrates the firm’s commitment to investing in companies that have a substantial impact on healthcare in the region.

Growth and Expansion of Vitalis

Founded in Bogotá, Colombia, Vitalis has established itself as a vital manufacturer and distributor of injectable pharmaceuticals that serve hospitals, clinics, and pharmacies throughout Latin America. Since ACON’s acquisition of Vitalis in 2021, the company has undergone remarkable growth, significantly expanding its production capacity and upgrading its facilities to adhere to the highest quality and environmental standards.

Under ACON's stewardship, Vitalis has broadened its offerings to include over 700 registered pharmaceutical products. The company has successfully opened new commercial channels within Latin America, including a noteworthy expansion by acquiring a company in Chile. These strategic initiatives have positioned Vitalis as one of Latin America's largest suppliers of injectable pharmaceuticals—a testament to its operational excellence and market foresight.

A Successful Investment Journey

The sale of Vitalis marks another successful chapter for ACON Investments, showcasing its disciplined, value-driven approach. Alberto Hernández, a partner at the firm, stated, "This has been a very successful investment for us and exemplifies ACON's ability to deliver strong performance despite dynamic market conditions." Hernández further emphasized the emphasis placed on sustainable growth and innovation during their partnership with Vitalis.

This transaction is a continuation of ACON's successful track record; in recent years, the firm has performed well with exits from notable investments such as Dorí Alimentos S.A. and Conexão Group in Brazil. ACON boasts almost three decades of experience in Latin America, where it has invested in 44 companies across ten nations, facilitating growth and supporting management teams.

The Role of Advisors

Although the specifics of the transaction were not disclosed, it is known that BTG Pactual served as the exclusive financial advisor to ACON regarding this sale. Additionally, several prestigious advisory firms, including Brigard Urrutia, Galicia Abogados, Hogan Lovells, Carey Abogados, McCarthy Tetrault, and Grant Thornton, played key roles in the transaction process.

About ACON Investments

Established in Washington, D.C., ACON Investments manages a diverse portfolio of private equity funds specializing in various sectors across the United States, Latin America, and Europe. With an impressive track record of managing $7.2 billion in assets, ACON has cultivated an international presence, with professionals located in major cities including Dallas, Los Angeles, New York, Bogotá, Madrid, Mexico City, and São Paulo. The firm continues to prioritize investing in high-potential companies that contribute positively to their communities and the environment.

For further inquiries about ACON Investments' latest activities or to learn more about their investment philosophy, you can visit their official website at www.aconinvestments.com.